Advertisement

Skin Cancer Prevention

  • Maria Lluria-Prevatt
  • David S. Alberts

Keywords

Skin Cancer Chemoprevention Agent Skin Carcinogenesis Nonmelanoma Skin Cancer Perillyl Alcohol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cancer Progress Report 2001 (2001). U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute. 2001.Google Scholar
  2. (2002). "Discussed in Calbiochem online catalog (Catalog No. 559388).&quotGoogle Scholar
  3. (2002). "Treatment of actinic keratosis now covered under Medicare." Oncology. 141.Google Scholar
  4. Albanell, J., F. Rojo, et al. (2002). "Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition." J Clin Oncol 20(1): 110–124.CrossRefPubMedGoogle Scholar
  5. Alberts, D., J. Ranger-Moore, et al. (2004). "Safety and efficacy study of dose intensive oral vitamin A in participants with sun damaged skin." Clin Cancer Res 10: 1875–1880.CrossRefPubMedGoogle Scholar
  6. Alberts, D.S., R.T. Dorr, et al. (2000). "Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine." Cancer Epidemiol Biomarkers Prev 9(12): 1281–1286.PubMedGoogle Scholar
  7. Almahroos, M. and A.K. Kurban (2004). "Ultraviolet Carcinogenesis in Nonmelanoma Skin Cancer. Part 1: Incidence Rates in Relation to Geographic Locations and in Malignant Populations." SKINmed 3(1): 29–35.PubMedGoogle Scholar
  8. An, K.P. et al. (2002). "Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches." Photochem Photobiol 76: 73–80.CrossRefPubMedGoogle Scholar
  9. Angel, P., K. Hattori, et al. (1988). "The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1." Cell 55(5): 875–885.CrossRefPubMedGoogle Scholar
  10. Aszterbaum, M., A. Rothman, et al. (1998). "Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome." J Invest Dermatol 110(6): 885–888.CrossRefPubMedGoogle Scholar
  11. Auger, K.R., L.A. Serunian, et al. (1989). "PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells." Cell 57(1): 167–175.CrossRefPubMedGoogle Scholar
  12. Autier, P., J.F. Dore, et al. (1995). "Melanoma and use of sunscreens: an EORTC case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group." Int J Cancer 61(6): 749–755.PubMedGoogle Scholar
  13. Bachelor, M.A. and G.T. Bowden (2004). "UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression." Semin Cancer Biol 14(2): 131–138.CrossRefPubMedGoogle Scholar
  14. Bachelor, M.A., A. L. Silvers, et al. (2002). "The role of p38 in UVA-induced cyclooxygenase-2 expression in the human keratinocyte cell line, HaCaT." Oncogene 21(46): 7092–7099.CrossRefPubMedGoogle Scholar
  15. Bair, W.B., 3rd, N. Hart, et al. (2002). "Inhibitory effects of sodium salicylate and acetylsalicylic acid on UVB-induced mouse skin carcinogenesis." Cancer Epidemiol Biomarkers Prev 11(12): 1645–1652.PubMedGoogle Scholar
  16. Baldi, A., D. Santini, et al. (2001). "Expression of AP-2 transcription factor and of its downstream target genes c-kit, E-cadherin and p21 in human cutaneous melanoma." J Cell Biochem 83(3): 364–372.CrossRefPubMedGoogle Scholar
  17. Bartels, P. H., J. Ranger-Moore, et al. (2002). "Statistical analysis of chemopreventive efficacy of vitamin A in sun-exposed, normal skin." Anal Quant Cytol Histol 24(4): 185–197.PubMedGoogle Scholar
  18. Barthelman, M., W. Bair, K. Kramer-Strickland, W. Chen, B. Timmerman, S. Valic, Z. Dong, G.T. Bowden (1998). "(—)-epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity." Carcinogenesis 19(12): 2001–2204.CrossRefPubMedGoogle Scholar
  19. Barthelman, M., W. Chen, et al. (1998). "Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation." Cancer Res 58(4): 711–716.PubMedGoogle Scholar
  20. Barton, J.K., K. Gossage, et al. (2003). "Investigating sundamaged skin and actinic keratosis with optical coherence tomography: a pilot study." Technol Cancer Res Treat 2(6): 1–11.PubMedGoogle Scholar
  21. Basset-Seguin, N., C. Escot, et al. (1990). "High levels of c-fos proto-oncogene expression in normal human adult skin." J Invest Dermatol 94(4): 418–422.CrossRefPubMedGoogle Scholar
  22. Beitner, H., S.E. Norell, et al. (1990). "Malignant melanoma: aetiological importance of individual pigmentation and sun exposure." Br J Dermatol 122(1): 43–51.Google Scholar
  23. Bennett, B.L., D.T. Sasaki, et al. (2001). "SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase." Proc Natl Acad Sci USA 98(24): 13681–13686.CrossRefPubMedGoogle Scholar
  24. Berman, B., C.A. Ricotti, Jr., et al. (2004). "Determination of the area of skin capable of being covered by the application of 250 mg of 5% imiquimod cream." Dermatol Surg 30(5): 784–786.CrossRefPubMedGoogle Scholar
  25. Bibbo, M., P.H. Bartels, et al. (1986). "Markers for malignancy in the nuclear texture of histologically normal tissue from patients with thyroid tumors." Anal Quant Cytol Histol 8(2): 168–176.PubMedGoogle Scholar
  26. Bibbo, M., F. Michelassi, et al. (1990). "Karyometric marker features in normal-appearing glands adjacent to human colonic adenocarcinoma." Cancer Res 50(1): 147–151.PubMedGoogle Scholar
  27. Bishop, D.T., F. Demenais, et al. (2002). "Geographical variation in the penetrance of CDKN2A mutations for melanoma." J Natl Cancer Inst 94: 894–903.PubMedGoogle Scholar
  28. Bjornhagen, V., E. Bonfoco, et al. (1994). "Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma." Am J Dermatopathol 16(6): 615–623.PubMedGoogle Scholar
  29. Borland, R., R. Marks, et al. (1992). "Public knowledge about characteristics of moles and melanomas." Aust J Public Health 16(4): 370–375.PubMedGoogle Scholar
  30. Bowden, G.T. (2004). "Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling." Nat Rev Cancer 4(1): 23–35.CrossRefPubMedGoogle Scholar
  31. Bozzo, P., D.S. Alberts, et al. (2001). "Measurement of chemopreventive efficacy in skin biopsies." Anal Quant Cytol Histol 23(4): 300–312.PubMedGoogle Scholar
  32. Bozzo, P.D., L.C. Vaught, et al. (1998). "Nuclear morphometry in solar keratosis." Anal Quant Cytol Histol 20(1): 21–28.PubMedGoogle Scholar
  33. Brash, D.E., J.A. Rudolph, et al. (1991). "A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma." Proc Natl Acad Sci USA 88(22): 10124–10128.PubMedGoogle Scholar
  34. Bregman, M. D. and F. L. Meyskens, Jr. (1986). "Difluoromethylornithine enhances inhibition of melanoma cell growth in soft agar by dexamethasone, clone A interferon and retinoic acid." Int J Cancer 37(1): 101–107.PubMedGoogle Scholar
  35. Buchwald, H. (1992). "Cholesterol inhibition, cancer and chemotherapy." Lancet 339: 1154–1156.CrossRefPubMedGoogle Scholar
  36. Buckman, S.Y., A. Gresham, et al. (1998). "COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer." Carcinogenesis 19(5): 723–729.CrossRefPubMedGoogle Scholar
  37. Burren, R., C. Scaletta, et al. (1998). "Sunlight and carcinogenesis: expression of p53 and pyrimidine dimers in human skin following UVA I, UVA I + II and solar simulating radiations." Int J Cancer 76(2): 201–206.CrossRefPubMedGoogle Scholar
  38. Burton, R.C. (2000). "Malignant Melanoma in the year 2000." CA Cancer J Clin 50: 209–213.PubMedGoogle Scholar
  39. Callen, J.P. (2000). "Statement on Actinic Keratosis." J Am Acad Dermatol 42(1 Part 2): 1.CrossRefGoogle Scholar
  40. Chen, N., M. Nomura, et al. (2001). "Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice." Cancer Res 61(10): 3908–3912.PubMedGoogle Scholar
  41. Chen, W., A.H. Borchers, et al. (1998). "UVB irradiation-induced activator protein-1 activation correlates with increased c-fos gene expression in a human keratinocyte cell line." J Biol Chem 273(48): 32176–32181.CrossRefPubMedGoogle Scholar
  42. Chen, W. and G.T. Bowden (1999). "Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes." Oncogene 18(52): 7469–7476.CrossRefPubMedGoogle Scholar
  43. Chen, W. and G.T. Bowden (2000). "Role of p38 mitogen-activated protein kinases in ultraviolet-B irradiation-induced activator protein 1 activation in human keratinocytes." Mol Carcinog 28: 196–202.CrossRefPubMedGoogle Scholar
  44. Chen, W., Z. Dong, et al. (1999). "Inhibition of ultraviolet B-induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (—)-epigallocatechin gallate in a human keratinocyte cell line." Mol Carcinog 24(2): 79–84.CrossRefPubMedGoogle Scholar
  45. Chen, W., Q. Tang, et al. (2001). "Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes." Oncogene 20(29): 3921–3926.CrossRefPubMedGoogle Scholar
  46. Clark, L.C., G.F. Combs, et al. (1996). "Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. National Prevention of Cancer Study Group." JAMA 276(1957–1963).CrossRefPubMedGoogle Scholar
  47. Cohen, B., Y.X. Liu, et al. (1990). "Characterization of p85, a target of oncogenes and growth factor receptors." Mol Cell Biol 10(6): 2909–2915.PubMedGoogle Scholar
  48. Cohen, C., A. Zavala-Pompa, et al. (2002). "Mitogen-activated protein kinase activation is an early event in melanoma progression." Clin Cancer Res 8(12): 3728–3733.PubMedGoogle Scholar
  49. Coso, O.A., M. Chiariello, et al. (1995). "Transforming G protein-coupled receptors potently activate JNK (SAPK). Evidence for a divergence from the tyrosine kinase signaling pathway." J Biol Chem 270(10): 5620–5624.CrossRefPubMedGoogle Scholar
  50. Crowell, PL. (1999). "Prevention and therapy of cancer by dietary monoterpenes." J Nutr 129(3): 775S–778S.PubMedGoogle Scholar
  51. Curran, T. and B.R. Franza, Jr. (1988). "Fos and Jun: the AP-1 connection." Cell 55(3): 395–397.CrossRefPubMedGoogle Scholar
  52. Davies, H., G.R. Bignell, et al. (2002). "Mutations of the BRAF gene in human cancer." Nature 417(6892): 949–954.CrossRefPubMedGoogle Scholar
  53. De Fabo, E.C., F.P. Noonan, et al. (2004). "Ultraviolet B but not ultraviolet A radiation initiates melanoma." Cancer Res 64(18): 6372–6376.CrossRefPubMedGoogle Scholar
  54. de Gruijl, F.R. (2000). "Photocarcinogenesis: UVA vs UVB." Methods Enzymol 319: 359–366.PubMedGoogle Scholar
  55. Del Rosso, J.Q. (2003). "New and emerging topical approaches for actinic keratoses." Cutis 72(4): 273–276, 279.PubMedGoogle Scholar
  56. Dellavalle, R.P., M.K. Nicholas, et al. (2003). "Melanoma Chemoprevention: A role for statins of fibrates." Am J Ther 10: 203–210.CrossRefPubMedGoogle Scholar
  57. Denkert, C., M. Kobel, et al. (2001). "Expression of cyclooxygenase 2 in human malignant melanoma." Cancer Res 61(1): 303–308.PubMedGoogle Scholar
  58. Derijard, B., M. Hibi, et al. (1994). "JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain." Cell 76(6): 1025–1037.CrossRefPubMedGoogle Scholar
  59. Diepgen, T. L. and V. Mahler (2002). "The epidemiology of skin cancer." Br J Dermotol 146(Suppl 61): 1–6.CrossRefGoogle Scholar
  60. Dinehart, S.M. (2000). "The treatment of actinic keratoses." J Am Acad Dermatol 42(1 Pt 2): 25–28.CrossRefGoogle Scholar
  61. Dinehart, S.M., P. Nelson-Adesokan, et al. (1997). "Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis." Cancer 79(5): 920–923.CrossRefPubMedGoogle Scholar
  62. Dissanayake, N.S., G.E. Greenoak, et al. (1993). "Effects of ultraviolet irradiation on human skin-derived epidermal cells in vitro." J Cell Physiol 157(1): 119–127.CrossRefPubMedGoogle Scholar
  63. Domann, F.E., J.P. Levy, et al. (1994). "Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice." Cell Growth Differ 5: 9–16.PubMedGoogle Scholar
  64. Dong, Z., M.J. Birrer, et al. (1994). "Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells." Proc Natl Acad Sci USA 91(2): 609–613.PubMedGoogle Scholar
  65. Dong, Z., C. Huang, et al. (1998). "Increased synthesis of phosphocholine is required for UV-induced AP-1 activation." Oncogene 17(14): 1845–1853.CrossRefPubMedGoogle Scholar
  66. Dorr, R.T., K. Dvorakova, et al. (2000). "Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4-D-Phe7]-alpha-MSH in humans." Photochem Photobiol 72(4): 526–532.CrossRefPubMedGoogle Scholar
  67. Downes, C.P. and A.N. Carter (1991). "Phosphoinositide 3-kinase: a new effector in signal transduction?" Cell Signal 3(6): 501–513.CrossRefPubMedGoogle Scholar
  68. Dracopoli, N.C., G.A. Bruns, et al. (1994). "Report and abstracts of the First International Workshop on Human Chromosome 1 Mapping 1994. Bethesda, Maryland, March 25–27, 1994." Cytogenet Cell Genet 67(3): 144–165.PubMedGoogle Scholar
  69. Dvorakova, K., R.T. Dorr, et al. (1999). "Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin." Cancer Chemother Pharmacol 43(4): 331–335.CrossRefPubMedGoogle Scholar
  70. Einspahr, J., D.S. Alberts, et al. (1996). "Evaluation of proliferating cell nuclear antigen as a Surrogate end point biomarker in actinic keratosis and adjacent, normal-appearing, and non-sun-exposed human skin samples." Cancer Epidemiol Biomarkers Prev 5(5): 343–348.PubMedGoogle Scholar
  71. Einspahr, J.G., D.S. Alberts, et al. (1997). "Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials." Cancer Epidemiol Biomarkers Prev 6(1): 37–48.PubMedGoogle Scholar
  72. Einspahr, J.G., D.S. Alberts, et al. (1999). "Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis." Neoplasia 1(5): 468–475.CrossRefPubMedGoogle Scholar
  73. Einspahr, J.G., G.T. Bowden, et al. (2003). "Skin cancer chemoprevention: strategies to save our skin." Recent Results Cancer Res 163: 151–164.PubMedGoogle Scholar
  74. Einspahr, J.G., M.A. Nelson, et al. (2002). "Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer." Clin Cancer Res 8(1): 149–155.PubMedGoogle Scholar
  75. English, D. R., B. K. Armstrong, et al. (1998). "Demographic characteristics, pigmentary and cutanous risk factors of squamous cell carcinoma of the skin. A case-control study." Int J Cancer 76: 628–634.CrossRefPubMedGoogle Scholar
  76. Falch, J., I. Antoni, et al. (2000). "The mevalonate/isoprenoid pathway inhibitor apomine (SR-45023A) is antiproliferative and induces apoptosis similar to farnesol." Biochem Biophys Res Commun 270: 240–246.CrossRefPubMedGoogle Scholar
  77. Fercher, A., K. Mengedoht, et al. (1988). "Eye length measurement by interferometry with partially coherent Light." Opt Lett 13: 186–188.Google Scholar
  78. Fisher, B., J.P. Costantino, et al. (1998). "Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study." J Natl Cancer Inst 90(18): 1371–1388.CrossRefPubMedGoogle Scholar
  79. Fisher, C., M. R. Byers, et al. (1991). "Patterns of epithelial expression of Fos protein suggest important role in the transition from viable to cornified cell during keratinization." Development 111(2): 253–258.PubMedGoogle Scholar
  80. Fisher, G.J. and J.J. Voorhees (1998). "Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce Ap-1-regulated matrix metalloproteinases that degrade human skin in vivo." J Investig Dermatol Symp Proc 3(1): 61–68.PubMedGoogle Scholar
  81. Foote, J.A., R.B. Harris, et al. (2001). "Predictors for cutaneous basal-and squamous-cell carcinoma among actinically damaged adults." Int J Cancer 95(1): 7–11.CrossRefPubMedGoogle Scholar
  82. Frankel, D.H., B.H. Hanusa, et al. (1992). "New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up." J Am Acad Dermatol 26(5 Pt 1): 720–726.PubMedGoogle Scholar
  83. Fry, D.W., A.J. Kraker, et al. (1994). "A specific inhibitor of the epidermal growth factor receptor tyrosine kinase." Science 265: 1093–1095.PubMedGoogle Scholar
  84. Funasaka, Y., T. Boulton, et al. (1992). "c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas." Mol Biol Cell 3(2): 197–209.PubMedGoogle Scholar
  85. Gallagher, T.F., G.L. Seibel, et al. (1997). "Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase." Bioorg Med Chem 5(1): 49–64.CrossRefPubMedGoogle Scholar
  86. Gause, P.R., M. Lluria-Prevatt, et al. (1997). "Chromosomal and genetic alterations of 7,12-dimethylbenz[a]anthracene-induced melanoma from TP-ras transgenic mice." Mol Carcinog 20(1): 78–87.CrossRefPubMedGoogle Scholar
  87. Gazit, A. et al. (1996). "Tyrphostins IV — highly potent inhibitors of EGF receptor kinase. Structure-activity relationship study of 4-anilidoquinazolines." Bioorg Med Chem 4: 1203–1207.CrossRefPubMedGoogle Scholar
  88. Geilen, C.C., M. Wieprecht, et al. (1996). "The mitogen-activated protein kinases system (MAP kinase cascade): its role in skin signal transduction. A review." J Dermatol Sci 12(3): 255–262.CrossRefPubMedGoogle Scholar
  89. Geller, A.C., G. Colditz, et al. (2002). "Use of sunscreen, sunburning rates, and tanning bed use among more than 10,000 US children and adolescents." Pediatrics 109(6): 1009–1014.CrossRefPubMedGoogle Scholar
  90. Gensler, H.L. (1991). "Prevention by alpha-difluoromethylornithine of skin carcinogenesis and immunosuppression induced by ultraviolet irradiation." J Cancer Res Clin Oncol 117(4): 345–350.CrossRefPubMedGoogle Scholar
  91. Ghosh, S., W.Q. Xie, et al. (1994). "The cysteine-rich region of raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to a segment that binds GTP-ras." J Biol Chem 269(13): 10000–10007.PubMedGoogle Scholar
  92. Gianpaolo-Ostravage, C., D. Bankston, et al. (2001). "Anti-tumor efficacy of the orally active Raf kinase inhibitor BAY 43-9006 in human tumor xenograft models." AACR 92(4954).Google Scholar
  93. Gilchrest, B.A., M.S. Eller, et al. (1999). "The pathogenesis of melanoma induced by ultraviolet radiation [comment]." N Engl J Med 340(17): 1341–1348.CrossRefPubMedGoogle Scholar
  94. Giles, G.G., R. Marks, et al. (1988). "Incidence of non-melanocytic skin cancer treated in Australia." Br Med J (Clin Res Ed) 296(6614): 13–17.Google Scholar
  95. Gillardon, F., C. Eschenfelder, et al. (1994). "Differential regulation of c-fos, fosB, c-jun, junB, bcl-2 and bax expression in rat skin following single or chronic ultraviolet irradiation and in vivo modulation by antisense oligodeoxynucleotide superfusion." Oncogene 9(11): 3219–3225.PubMedGoogle Scholar
  96. Glass, A.G. and R. N. Hoover (1989). "The emerging epidemic of melanoma and squamous cell skin cancer." JAMA 262: 2097–2100.CrossRefPubMedGoogle Scholar
  97. Glogau, R.G. (2000). "The risk of progression to invasive disease." J Am Acad Dermatol 42(1 Pt 2): 23–24.CrossRefPubMedGoogle Scholar
  98. Goldstein, A. M. and M.A. Tucker (2001). "Genetic epidemiology of cutaneous melanoma. A global perspective." Arch Dermatol 137: 1493–1496.PubMedGoogle Scholar
  99. Gonzales, M. and G.T. Bowden (2002). "Nordihydroguaiaretic acid-mediated inhibition of ultraviolet B-induced activator protein-1 activation in human keratinocytes." Mol Carcinog 34(2): 102–111.CrossRefPubMedGoogle Scholar
  100. Gould, M.N., C.J. Moore, et al. (1994). "Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras." Cancer Res 54(13): 3540–3543.PubMedGoogle Scholar
  101. Graham, S., J. Marshall, et al. (1985). "An inquiry into the epidemiology of melanoma." Am J Epidemiol 122(4): 606–619.PubMedGoogle Scholar
  102. Green, A. (1992). "Changing patterns in incidence of non-melanoma skin cancer." Epithelial Cell Biol 1(1): 47–51.CrossRefPubMedGoogle Scholar
  103. Greenberg, E.R., J.A. Baron, et al. (1990). "A clinical trial of beta carotene to prevent basal-cell and squamous cell cancers of the skin." N Engl J Med 323: 789–795.PubMedGoogle Scholar
  104. Greene, M. H. (1997). "Genetics of cutaneous melanoma and nevi." Mayo Clin Proc 72(5): 467–474.PubMedGoogle Scholar
  105. Greene, M.H., W.H. Clark, Jr., et al. (1985). "Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome." N Engl J Med 312(2): 91–97.PubMedGoogle Scholar
  106. Greene, M.H., W.H. Clark, Jr., et al. (1985). "High risk of malignant melanoma in melanoma-prone families with dysplastic nevi." Ann Intern Med 102(4): 458–465.PubMedGoogle Scholar
  107. Gudas, L.J. (1994). "Retinoids and vertebrate development." J Biol Chem 269(22): 15399–15402.PubMedGoogle Scholar
  108. Haag, J.D. and M.N. Gould (1994). "Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene." Cancer Chemother Pharmacol 34(6): 477–483.PubMedGoogle Scholar
  109. Haake, A.R. and R. R. Polakowska (1993). "Cell death by apoptosis in epidermal biology." J Invest Dermatol 101(2): 107–112.CrossRefPubMedGoogle Scholar
  110. Halaban, R., Fan, B., Ahn, J., Funasaka, Y., Gitay-Goren, H., Neufeld, G. (1992). "Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes." J Immunother 12: 154–161.PubMedGoogle Scholar
  111. Halaban, R., J.S. Rubin, et al. (1992). "Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells." Oncogene 7(11): 2195–2206.PubMedGoogle Scholar
  112. Halachmi, S. and B.A. Gilchrest (2001). "Update on genetic events in the pathogenesis of melanoma." Curr Opin Oncol 13(2): 129–136.CrossRefPubMedGoogle Scholar
  113. Hall, P.A., D.A. Levison, et al. (1990). "Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms." J Pathol 162(4): 285–294.CrossRefPubMedGoogle Scholar
  114. Haluska, F.G. and F.S. Hodi (1998). "Molecular genetics of familial cutaneous melanoma." J Clin Oncol 16(2): 670–682.PubMedGoogle Scholar
  115. Han, H., Boyle, D., Chang, L., Bennett, B., Karin, M., Manning, A., Firestein, G. (2001). "c-Jun N-terminal kinase is required for metalloproteinase expression and Joint destruction in inflammatory arthritis." J Clin Invest 108: 73–81.CrossRefPubMedGoogle Scholar
  116. Harris, R.B., Griffith, K., Moon, T.E. (2001). "Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985–1996." J Am Acad Dermatol 45(4): 528–536.CrossRefPubMedGoogle Scholar
  117. Harris, R.E., J. Beebe-Donk, et al. (2001). "Inverse association of non-steroidal anti-inflammatory drugs and malignant melanoma among women." Oncol Rep 8(3): 655–657.PubMedGoogle Scholar
  118. Herbert, J.L., F. Khugyani, et al. (2001). "Chemoprevention of basal cell carcinomas in the ptc1 +/− mouse — green and black tea." Skin Pharmacol Appl Skin Physiol 14(6): 358–362.CrossRefPubMedGoogle Scholar
  119. Herlyn, M. and K. Satyamoorthy (1996). "Activated ras. Yet another player in melanoma?" Am J Pathol 149(3): 739–744.PubMedGoogle Scholar
  120. Hill, C.S. and R. Treisman (1995). "Transcriptional regulation by extracellular signals: mechanisms and specificity." Cell 80(2): 199–211.CrossRefPubMedGoogle Scholar
  121. Hill, D., V. White, et al. (1993). "Changes in sun-related attitudes and behaviours, and reduced sunburn prevalence in a population at high risk of melanoma." Eur J Cancer Prev 2(6): 447–456.PubMedGoogle Scholar
  122. Hohl, R.J. and K. Lewis (1995). "Differential effects of monoterpenes and lovastatin on RAS processing." J Biol Chem 270(29): 17508–17512.CrossRefPubMedGoogle Scholar
  123. Housman, T.S., S.R. Feldman, et al. (2003). "Skin Cancer is among the most costly of all cancers to treat for the Medicare population." J Acad Dermatol 48: 425–429.CrossRefGoogle Scholar
  124. Huang, C., W. Ma, et al. (1997). "Direct evidence for an important role of sphingomyelinase in ultraviolet-induced activation of c-Jun N-terminal kinase." J Biol Chem 272(44): 27753–27757.CrossRefPubMedGoogle Scholar
  125. Huang, C., W.Y. Ma, et al. (1997). "Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3′ kinase." Cancer Res 57(14): 2873–2878.PubMedGoogle Scholar
  126. Huang, C., W.Y. Ma, C.A. Ryan, Z. Dong (1997). "Proteinase inhibitors I and II from potatoes specifically block UV-induced activator protein-1 activation through a pathway that is independent of extracellular signal-regulated kinases, c-Jun N-terminal kinases, and p38 kinases." Proc Natl Acad Sci USA 94: 11957–11962.CrossRefPubMedGoogle Scholar
  127. Hunter, T. (1997). "Oncoprotein networks." Cell 88(3): 333–346.CrossRefPubMedGoogle Scholar
  128. Hussussian, C.J., J.P. Struewing, et al. (1994). "Germline p16 mutations in familial melanoma." Nat Genet 8(1): 15–21.CrossRefPubMedGoogle Scholar
  129. International Medical News Group (2002). "Nonmelanoma skin cancer new solutions to treatment." Supplement to Skin and Allergy News.Google Scholar
  130. Irinopoulou, T., J.P. Rigaut, et al. (1993). "Toward objective prognostic grading of prostatic carcinoma using image analysis." Anal Quant Cytol Histol 15(5): 341–344.PubMedGoogle Scholar
  131. Jansen, B., V. Wacheck, et al. (2000). "Chemosensitisation of malignant melanoma by BCL2 antisense therapy." Lancet 356(9243): 1728–1733.CrossRefPubMedGoogle Scholar
  132. Jermal, A., R.C. Tiwan, et al. (2004). "Cancer Statistics 2004." CA Cancer J Clin 54: 8–29.PubMedGoogle Scholar
  133. Kabayama, Y., M. Hamaya, et al. (1998). "Wavelength specific activation of PI3-kinase by UVB irradiation." FEBS Letters 441: 297–301.CrossRefPubMedGoogle Scholar
  134. Kallunki, T., B. Su, et al. (1994). "JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation." Genes Dev 8(24): 2996–3007.PubMedGoogle Scholar
  135. Kamb, A., D. Shattuck-Eidens, et al. (1994). "Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus." Nat Genet 8(1): 23–26.CrossRefPubMedGoogle Scholar
  136. Kerr, J.F., A.H. Wyllie, et al. (1972). "Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics." Br J Cancer 26(4): 239–257.PubMedGoogle Scholar
  137. Klepp, O. and K. Magnus (1979). "Some environmental and bodily characteristics of melanoma patients. A case-control study." Int J Cancer 23(4): 482–486.PubMedGoogle Scholar
  138. Koh, H.K. (1991). "Cutaneous melanoma [comment]." N Engl J Med 325(3): 171–182.PubMedGoogle Scholar
  139. Kolch, W., G. Heidecker, et al. (1993). "Protein kinase C alpha activates RAF-1 by direct phosphorylation." Nature 364(6434): 249–252.CrossRefPubMedGoogle Scholar
  140. Konig, H., H. Ponta, et al. (1992). "Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo." Embo J 11(6): 2241–2246.PubMedGoogle Scholar
  141. Lahti, J.M., J. Xiang, et al. (1995). "PITSLRE protein kinase activity is associated with apoptosis." Mol Cell Biol 15(1): 1–11.PubMedGoogle Scholar
  142. Lambert, J.D., R.O. Meyers, et al. (2001). "Tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo." Cancer Lett 171(1): 47–56.CrossRefPubMedGoogle Scholar
  143. Lang, P.G., Maize, J.C. (1991). Basal Cell Carcinoma. Cancer of the Skin. R. Friedman, D.S. Rigel, A.W. Kopf, M.N. Harris and D. Baker. Philadelphia, W.B. Saunders. 14–24.Google Scholar
  144. Lee, J.C., A.M. Badger, et al. (1993). "Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors." Ann NY Acad Sci 696: 149–170.PubMedGoogle Scholar
  145. Lee, J.C., D.E. Griswold, et al. (1988). "Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002." Int J Immunopharmacol 10(7): 835–843.CrossRefPubMedGoogle Scholar
  146. Lee, J.C., S. Kumar, et al. (2000). "Inhibition of p38 MAP kinase as a therapeutic strategy." Immunopharmacology 47(2–3): 185–201.CrossRefPubMedGoogle Scholar
  147. Lee, W., A. Haslinger, et al. (1987). "Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40." Nature 325(6102): 368–372.CrossRefPubMedGoogle Scholar
  148. Lens, M.B. and M. Dawes (2004). "Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma." Br J Cancer 150(2): 179–185.Google Scholar
  149. Levine, N., R.T. Dorr, G.A. Ertl, C. Brooks, D.S. Alberts (1999). "Effects of a potent synthetic melanotropin, Nl4-D-Phe7-MSH (Melanotant-1) on tanning: a dose range study." J Dermatol Treatment 10: 127–132.Google Scholar
  150. Li, G. and M. Herlyn (2000). "Dynamics of intercellular communication during melanoma development." Mol Med Today 6(4): 163–169.CrossRefPubMedGoogle Scholar
  151. Liaw, G.J., E. Steingrimsson, F. Pignoni, A.J. Courey, J.A. Lengyel (1993). "Characterization of downstream elements in Raf-1 pathway." Proc Natl Acad Sci USA 90: 858–862.PubMedGoogle Scholar
  152. Liggett, W.H., Jr. and D. Sidransky (1998). "Role of the p16 tumor suppressor gene in cancer." J Clin Oncol 16(3): 1197–1206.PubMedGoogle Scholar
  153. Lippman, S.M. and P.H. Brown (1999). "Tamoxifen prevention of breast cancer: an instance of the fingerpost." J Natl Cancer Inst 91(21): 1809–1819.CrossRefPubMedGoogle Scholar
  154. Lippman, S.M. and W.K. Hong (2002). "Cancer prevention by delay. Commentary: J.A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin Cancer Res 8: 314–346, 2002." Clin Cancer Res 8(2): 305–313.PubMedGoogle Scholar
  155. Lippman, S.M., J.S. Lee, et al. (1990). "Biomarkers as intermediate end points in chemoprevention trials." J Natl Cancer Inst 82(7): 555–560.PubMedGoogle Scholar
  156. Lluria-Prevatt, M., J. Morreale, et al. (2002). "Effects of perillyl alcohol on melanoma in the TPras mouse model." Cancer Epidemiol Biomarkers Prev 11(6): 573–579.PubMedGoogle Scholar
  157. Lorusso, P.M. (2003). "Phase I studies of ZD1839 in patients with common solid tumors." Semin Oncol 30(Suppl 1): 21–29.CrossRefGoogle Scholar
  158. Lyons, J.F., S. Wilhelm, et al. (2001). "Discovery of a novel Raf kinase inhibitor." Endocr Relat Cancer 8(3): 219–225.CrossRefPubMedGoogle Scholar
  159. MacAulay, C., S. Lam, et al. (1995). "Malignancy-associated changes in bronchial epithelial cells in biopsy specimens." Anal Quant Cytol Histol 17(1): 55–61.Google Scholar
  160. Mangelsdorf, D., K. Unesonso, et al. (1994). The Retinoid Receptors. The Retinoids. M.B. Sporn, A.B. Roberts and D.S. Goodman. New York, Raven Press. 319–349.Google Scholar
  161. Manson, J.E., K.M. Rexrode, et al. (2000). "The case for a comprehensive national campaign to prevent melanoma and associated mortality." Epidemiology 11(6): 728–734.CrossRefPubMedGoogle Scholar
  162. Marks, R. (1999). "Two decades of the public health approach to skin cancer control in Australia: why, how and where are we now?" Australas J Dermatol 40(1): 1–5.CrossRefPubMedGoogle Scholar
  163. Marras, S., G. Faa, et al. (1999). "Chromosomal changes in dysplastic nevi." Cancer Genet Cytogenet 113(2): 177–179.CrossRefPubMedGoogle Scholar
  164. Marshall, C.J. (1995). "Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation." Cell 80(2): 179–185.CrossRefPubMedGoogle Scholar
  165. Matsumura, Y., C. Nishigori, et al. (1996). "Characterization of p53 gene mutations in basal-cell carcinomas: comparison between sun-exposed and less-exposed skin areas." Int J Cancer 65(6): 778–780.CrossRefPubMedGoogle Scholar
  166. McEwan, L.E. and J.G. Smith (1997). "Topical diclofenac/hyaluronic acid gel in the treatment of solar keratoses." Australas J Dermatol 38(4): 187–189.PubMedGoogle Scholar
  167. Meyskens, F.L., Jr. (1988). "Thinking about cancer causality and chemoprevention." J Natl Cancer Inst 80(16): 1278–1281.PubMedGoogle Scholar
  168. Meyskens, F. L., Jr., P.J. Farmer, et al. (2004). "Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk." Clin Cancer Res 10(8): 2581–2583.CrossRefPubMedGoogle Scholar
  169. Meyskens, F.L., E.M. Kingsley, T. Glattke, et al. (1986). "A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma." Inv New Drugs 4: 257–262.Google Scholar
  170. Mills, J.J., R.S. Chari, et al. (1995). "Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol." Cancer Res 55(5): 979–983.PubMedGoogle Scholar
  171. Moon, T. E., N. Levine, et al. (1997). "Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group." Cancer Epidemiol Biomarkers Prev 6(11): 949–956.PubMedGoogle Scholar
  172. Morse, M.A. and G. D. Stoner (1993). "Cancer chemoprevention: principles and prospects." Carcinogenesis 14(9): 1737–1746.PubMedGoogle Scholar
  173. Nakazawa, H., D. English, et al. (1994). "UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement." Proc Natl Acad Sci USA 91(1): 360–364.PubMedGoogle Scholar
  174. Nelson, M.A., J.G. Einspahr, et al. (1994). "Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers." Cancer Letters 85(1): 23–29.CrossRefPubMedGoogle Scholar
  175. Niesor, E., J. Flach, et al. (1999). "Synthetic Farnesoid X Receptor (FXR) agonists: a new class of cholesterol synthesis inhibitors and antiproliferative drugs." Drugs Future 24: 431–438.CrossRefGoogle Scholar
  176. Nomura, M., A. Kaji, et al. (2001). "Mitogen-and stress-activated protein kinase 1 mediates activation of Akt by ultraviolet B irradiation." J Biol Chem 276(27): 25558–25567.CrossRefPubMedGoogle Scholar
  177. Nomura, M., W.Y. Ma, et al. (2000). "Inhibition of ultraviolet B-induced AP-1 activation by theaflavins from black tea." Mol Carcinog 28(3): 148–155.CrossRefPubMedGoogle Scholar
  178. Orengo, I.F., J. Gerguis, et al. (2002). "Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: a study in the hairless mouse model." Arch Dermatol 138(6): 751–755.CrossRefPubMedGoogle Scholar
  179. Ortonne, J.P. (2002). "Photobiology and genetics of malignant melanoma." Br J Dermatol 146(Suppl) 61: 11–16.CrossRefPubMedGoogle Scholar
  180. O'Shaughnessy, J.A., G.J. Kelloff, et al. (2002). "Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development [comment]." Clin Cancer Res 8(2): 314–346.PubMedGoogle Scholar
  181. Pentland, A.P., J.W. Schoggins, et al. (1999). "Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition." Carcinogenesis 20: 1939–1944.CrossRefPubMedGoogle Scholar
  182. Peyssonnaux, C. and A. Eychene (2001). "The Raf/MEK/ERK pathway: new concepts of activation." Biol Cell 93(1–2): 53–62.CrossRefPubMedGoogle Scholar
  183. Pierceall, W. E., L.H. Goldberg, et al. (1991). "Ras gene mutation and amplification in human nonmelanoma skin cancers." Mol Carcinog 4(3): 196–202.PubMedGoogle Scholar
  184. Pollock, P.M., U.L. Harper, et al. (2003). "High frequency of BRAF mutations in nevi." Nat Genet 33(1): 19–20.CrossRefPubMedGoogle Scholar
  185. Powell, M.B., D.S. Alberts, et al. (2002). "Preclinical and clinical activity of Apomine, a novel biophosphonate ester in the prevention and treatment of melanoma." Proc AACR.Google Scholar
  186. Powell M.B., P. Hyman, J. Gregus, M. Lluria-Prevatt, R. Nagle, G.T. Bowden (1999). "Induction of melanoma in TPras transgenic mice." Carcinogenesis 20(9): 1747–1753.CrossRefPubMedGoogle Scholar
  187. Powis, G., M. Berggren, et al. (1995). "Advances with phospholipid signalling as a target for anticancer drug development." Acta Biochim Pol 42(4): 395–403.PubMedGoogle Scholar
  188. Quinn, A.G., S. Sikkink, et al. (1994). "Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss." Cancer Res 54(17): 4756–4759.PubMedGoogle Scholar
  189. Randle, H. (1996). "Basal Cell Carcinoma. Identification and treatment of the high-risk patient." Dermatolog Surg 22: 255–261.CrossRefGoogle Scholar
  190. Reed, J.A., F. Loganzo, Jr., et al. (1995). "Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression." Cancer Res 55(13): 2713–2718.PubMedGoogle Scholar
  191. Rehman, I., M. Takata, et al. (1996). "Genetic change in actinic keratoses." Oncogene 12(12): 2483–2490.PubMedGoogle Scholar
  192. Richmond, A., R. Fine, et al. (1986). "Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas." J Invest Dermatol 86(3): 295–302.CrossRefPubMedGoogle Scholar
  193. Rigel, D.S. (2002). "The effect of sunscreen on melanoma risk." Dermatol Clin 20: 601–606.CrossRefPubMedGoogle Scholar
  194. Rivers, J.K., J. Arlette, et al. (2002). "Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel." Br J Dermatol 146(1): 94–100.CrossRefPubMedGoogle Scholar
  195. Rivers, J.K. and D.I. McLean (1997). "An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses." Arch Dermatol 133(10): 1239–1242.CrossRefPubMedGoogle Scholar
  196. Rubins, H.B., S.J. Robins, et al. (1999). "Gemifibrozil for the secondary prevention of coronary heart disease in men with low levels of high density lipoprotein cholesterol." N Engl J Med 341: 410–418.CrossRefPubMedGoogle Scholar
  197. Runger, T.M. (1999). "Role of UVA in the pathogenesis of melanoma and non-melanoma skin cancer. A short review." Photodermatol Photoimmunol Photomed 15(6): 212–216.PubMedGoogle Scholar
  198. Ryseck, R.P., S.I. Hirai, et al. (1988). "Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts." Nature 334(6182): 535–537.CrossRefPubMedGoogle Scholar
  199. Salasche, S.J. (2000). "Epidemiology of actinic keratoses and squamous cell carcinoma." J Am Acad Dermatol 42(1 Pt 2): 4–7.CrossRefPubMedGoogle Scholar
  200. Samuels, M.L., M.J. Weber, et al. (1993). "Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase." Mol Cell Biol 13(10): 6241–6252.PubMedGoogle Scholar
  201. Setlow, R. B., E. Grist, et al. (1993). "Wavelengths effective in induction of malignant melanoma." Proc Natl Acad Sci USA 90(14): 6666–6670.PubMedGoogle Scholar
  202. Sherman, A. and L. Koss (1983). "Morphometry of benign urothelial cells in the presence of cancer." Analyt Quant Cytol Histol 5: 221.Google Scholar
  203. Silvers, A.L., M.A. Bachelor, et al. (2003). "The role of JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression." Neoplasia 5(4): 319–329.PubMedGoogle Scholar
  204. Silvers, A.L. and G.T. Bowden (2002). "UVA irradiation-induced activation of activator protein-1 is correlated with induced expression of AP-1 family members in the human keratinocyte cell line HaCaT." Photochem Photobiol 75(3): 302–310.CrossRefPubMedGoogle Scholar
  205. Sober, A.J. and J.M. Burstein (1995). "Precursors to skin cancer." Cancer 75(2 Suppl): 645–650.PubMedGoogle Scholar
  206. Soufir, N., M.F. Avril, et al. (1998). "Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group." Hum Mol Genet 7(2): 209–216.CrossRefPubMedGoogle Scholar
  207. Soufir, N., J.P. Moles, et al. (1999). "P16 UV mutations in human skin epithelial tumors." Oncogene 18(39): 5477–5481.CrossRefPubMedGoogle Scholar
  208. Spencer, J.M., S. M. Kahn, et al. (1995). "Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas." Arch Dermatol 131(7): 796–800.CrossRefPubMedGoogle Scholar
  209. Sporn, M.B. and N. Suh (2000). "Chemoprevention of cancer." Carcinogenesis 21(3): 525–530.CrossRefPubMedGoogle Scholar
  210. Stam-Posthuma, J.J. (1998). "Effect of topical tretinoin under occlusion on atypical nevi." Melanoma Research 8: 539–548.PubMedGoogle Scholar
  211. Stam-Posthuma, J.J., C. van Duinen, et al. (2001). "Multiple primary melanomas." J Am Acad Dermatol 44(1):22–27.CrossRefPubMedGoogle Scholar
  212. Stayrook, K.R., J.H. McKinzie, et al. (1998). "Effects of the antitumor agent perillyl alcohol on H-Ras vs. K-Ras farnesylation and signal transduction in pancreatic cells." Anticancer Res 18(2A): 823–828.PubMedGoogle Scholar
  213. Stein, B., P. Angel, et al. (1992). "Ultraviolet-radiation induced c-jun gene transcription: two AP-1 like binding sites mediate the response." Photochem Photobiol 55(3): 409–415.PubMedGoogle Scholar
  214. Steinbach, G., P.M. Lynch, et al. (2000). "The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis." N Engl J Med 342(26): 1946–1952.CrossRefPubMedGoogle Scholar
  215. Stolz, W., T. Vogt, et al. (1994). "Differentiation between malignant melanomas and benign melanocytic nevi by computerized DNA cytometry of imprint specimens." J Cutan Pathol 21(1): 7–15.PubMedGoogle Scholar
  216. Stratton, S.P. (2001). "Prevention of non-melanoma skin cancer." Curr Oncol Rep 3: 295–300.PubMedGoogle Scholar
  217. Stratton, S.P., R.T. Dorr, et al. (2000). "The state-of-the-art in chemoprevention of skin cancer." Eur J Cancer 36(10): 1292–1297.CrossRefPubMedGoogle Scholar
  218. Straume, O. and L.A. Akslen (1997). "Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma." Int J Cancer 74(5): 535–539.CrossRefPubMedGoogle Scholar
  219. Strumberg, D., W. Schuehly, J.F. Moeller, D. Hedler, R. Hilger, W. Stellberg, H. Richly, R. Heinig, G. Ahr, G. Wensing, J. Kuhlmann, M.E. Scheulen, S. Seeber (2001). "Phase I clinical, pharmacokinetic and pharmacodynamic study of the Raf kinase inhibitor BAY 49-9006 in patients with locally advanced or metastatic cancer." Proc AACR 330.Google Scholar
  220. Susnik, B., A. Worth, et al. (1995). "Malignancy-associated changes in the breast. Changes in chromatin distribution in epithelial cells in normal-appearing tissue adjacent to carcinoma." Anal Quant Cytol Histol 17(1): 62–68.PubMedGoogle Scholar
  221. Swerdlow, A.J. and M.A. Weinstock (1998). "Do tanning lamps cause melanoma? An epidemiologic assessment." J Am Acad Dermatol 38(1): 89–98.PubMedGoogle Scholar
  222. Tada, A., E. Pereira, et al. (2002). "Mitogen-and Ultraviolet-B-Induced Signaling Pathways in Normal Human Melanocytes." J Invest Dermatol 118(2): 316–322.CrossRefPubMedGoogle Scholar
  223. Takigawa, M., M. Enomoto, et al. (1990). "Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in vivo and the proliferation of vascular endothelial cells in vitro." Cancer Res 50(13): 4131–4138.PubMedGoogle Scholar
  224. Tang, Q., M. Gonzales, et al. (2001). "Roles of Akt and glycogen synthase kinase 3beta in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes." Cancer Res 61(11): 4329–4332.PubMedGoogle Scholar
  225. Tangrea, J.A., B.K. Edwards, et al. (1992). "Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial." J Natl Cancer Inst 84: 328–332.PubMedGoogle Scholar
  226. Thompson, F.H., J. Emerson, et al. (1995). "Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes." Cancer Genet Cytogenet 83(2): 93–104.CrossRefPubMedGoogle Scholar
  227. Tsao, H. (2001). "Genetics of nonmelanoma skin cancer." Arch Dermatol 137(11): 1486–1492.PubMedGoogle Scholar
  228. Tsao, H., G.S. Roers, A.J. Sober (1998). "An estimate of the annual direct cost of treating cutaneous melanoma." J Am Acad Dermatol 38: 669–680.PubMedGoogle Scholar
  229. Uhlman, M. (2002). Teens take risks for tans: Sunscreen often goes by the wayside, a study shows. FDA is evaluating labeling. Philadelphia Inquirer. Philadelphia, PA. A08.Google Scholar
  230. Veierod, M.B., E. Weiderpass, et al. (2003). "A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women." J Natl Cancer Inst 95(20): 1530–1538.PubMedGoogle Scholar
  231. Vivanco, I. and C.L. Sawyers (2002). "The phosphatidylinositol 3-Kinase AKT pathway in human cancer." Nat Rev Cancer 2(7): 489–501.CrossRefPubMedGoogle Scholar
  232. Wakeling, A.E. (2002). "Epidermal growth factor receptor tyrosine kinase inhibitors." Curr Opin Pharmacol 24(4): 382–387.CrossRefGoogle Scholar
  233. Wakeling, A.E., G.P. Simon, et al. (2002). "An orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy." Cancer Res 62: 5749–5754.PubMedGoogle Scholar
  234. Wales, M.M., M.A. Biel, et al. (1995). "p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3." Nat Med 1(6): 570–577.CrossRefPubMedGoogle Scholar
  235. Wan, Y.S., Z.Q. Wang, et al. (2001). "Ultraviolet irradiation activates Pl 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo." Int J Oncol 18: 461–466.PubMedGoogle Scholar
  236. Wan, Y.S., Z.Q. Wang, et al. (2001). "EGF receptor crosstalks with cytokine receptors leading to the activation of c-Jun kinase in response to UV irradiation in human keratinocytes." Cell Signal 13: 139–144.CrossRefPubMedGoogle Scholar
  237. Wang, S.Q., R. Setlow, et al. (2001). "Ultraviolet A and melanoma: a review [comment]." J Am Acad Dermatol 44(5): 837–846.CrossRefPubMedGoogle Scholar
  238. Warne, P.H., P.R. Viciana, et al. (1993). "Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro." Nature 364(6435): 352–355.CrossRefPubMedGoogle Scholar
  239. Welzel, J. (2001). "Optical coherence tomography in dermatology: a review." Skin Res Technol 7(1): 1–9.CrossRefPubMedGoogle Scholar
  240. Weyn, B., W. Jacob, et al. (2000). "Data representation and reduction for chromatin texture in nuclei from premalignant prostatic, esophageal, and colonic lesions." Cytometry 41(2): 133–138.CrossRefPubMedGoogle Scholar
  241. Whitman, M., C.P. Downes, et al. (1988). "Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate." Nature 332(6165): 644–646.CrossRefPubMedGoogle Scholar
  242. Wied, G.L., P.H. Bartels, et al. (1980). "Cytomorphometric markers for uterine cancer in intermediate cells." Analytical & Quantitative Cytology 2(4): 257–263.Google Scholar
  243. Wikonkal, N.M. and D.E. Brash (1999). "Ultraviolet radiation induced signature mutations in photocarcinogenesis." J Investig Dermatol Symp Proc 4: 6–10.PubMedGoogle Scholar
  244. Wolf, J.E., Jr., J.R. Taylor, et al. (2001). "Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses." Int J Dermatol 40(11): 709–713.CrossRefPubMedGoogle Scholar
  245. Wolfe, P., C.K. Donawho, M. L. Kripke (1994). "Effects of sunscreen on UV radiation-induced enhancement of melanoma growth in mice." J Natl Cancer Inst 86(2): 99–105.PubMedGoogle Scholar
  246. Wymer, J.A., R. Taetle, J.M. Yang, J.M. Lahti, V.J. Kidd, M.A. Nelson (1997). "Alterations in the PITSLRE protein kinase gene complex on chromosome band 1p36 in melanoma." Proc AACR.Google Scholar
  247. Xu, X.C., J.L. Clifford, et al. (1994). "Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in situ hybridization histochemistry." Diagn Mol Pathol 3(2): 122–131.PubMedGoogle Scholar
  248. Yasuda, H., H. Kobayashi, et al. (1989). "Differential expression of ras oncogene products among the types of human melanomas and melanocytic nevi." J Invest Dermatol 93(1): 54–59.CrossRefPubMedGoogle Scholar
  249. Zhang, Y., Z. Dong, et al. (2001). "Induction of EGFR-dependent and EGFR-independent signaling pathways by ultraviolet A irradiation." DNA Cell Biology 20: 769–779.CrossRefGoogle Scholar
  250. Zhang, Y., S. Zhong, et al. (2001). "UVA induces Ser381 phosphorylation of p90RSK/MAP-KAP-K1 via ERK and JNK pathways." J Biol Chem 276(18): 14572–14580.CrossRefPubMedGoogle Scholar
  251. Ziegler, A., D.J. Leffell, et al. (1993). "Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers." Proc Natl Acad Sci USA 90(9): 4216–4220.PubMedGoogle Scholar
  252. Zou, L., Weger, J., Yang, Q., et al. (1996). "Germline mutations in the p16INK4a binding domain of CDK4 familial melanoma." Nat Genet 7: 209–216.Google Scholar

Copyright information

© Springer Berlin Heidelberg 2005

Authors and Affiliations

  • Maria Lluria-Prevatt
    • 1
  • David S. Alberts
    • 1
  1. 1.College of MedicineUniversity of ArizonaTucson

Personalised recommendations